[go: up one dir, main page]

TR200001262T2 - Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu - Google Patents

Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu

Info

Publication number
TR200001262T2
TR200001262T2 TR2000/01262T TR200001262T TR200001262T2 TR 200001262 T2 TR200001262 T2 TR 200001262T2 TR 2000/01262 T TR2000/01262 T TR 2000/01262T TR 200001262 T TR200001262 T TR 200001262T TR 200001262 T2 TR200001262 T2 TR 200001262T2
Authority
TR
Turkey
Prior art keywords
alkyl
active ingredients
alkoxy
alzheimer
treatment
Prior art date
Application number
TR2000/01262T
Other languages
English (en)
Turkish (tr)
Inventor
Maffrand Jean-Pierre
Soubrie Philippe
Terranova Jean-Paul
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200001262T2 publication Critical patent/TR200001262T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR2000/01262T 1997-11-14 1998-11-09 Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu TR200001262T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
TR200001262T2 true TR200001262T2 (tr) 2001-01-22

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01262T TR200001262T2 (tr) 1997-11-14 1998-11-09 Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu

Country Status (27)

Country Link
EP (1) EP1030671A1 (et)
JP (1) JP2001523642A (et)
KR (1) KR100599350B1 (et)
CN (1) CN1243540C (et)
AU (1) AU743228B2 (et)
BG (1) BG64819B1 (et)
BR (1) BR9814035A (et)
CA (1) CA2309966A1 (et)
CO (1) CO4980891A1 (et)
DZ (1) DZ2649A1 (et)
EA (1) EA003255B1 (et)
EE (1) EE04235B1 (et)
HU (1) HUP0100098A3 (et)
ID (1) ID24933A (et)
IL (2) IL136122A0 (et)
IS (1) IS5482A (et)
MY (1) MY120461A (et)
NO (1) NO20002450L (et)
NZ (1) NZ504420A (et)
OA (1) OA11464A (et)
PL (1) PL194597B1 (et)
SA (1) SA98190747B1 (et)
SK (1) SK286040B6 (et)
TR (1) TR200001262T2 (et)
TW (1) TW585766B (et)
UY (1) UY25247A1 (et)
WO (1) WO1999025363A1 (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04012534A (es) 2002-06-14 2005-04-19 Toyama Chemical Co Ltd Composicion farmaceutica para mejorar la funcion cerebral y metodo para mejorar la funcion cerebral.
WO2004015140A1 (en) * 2002-08-07 2004-02-19 Novartis Ag Methods for the treatment of dementia based on apo e genotype
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
MX368755B (es) 2014-01-31 2019-10-15 Cognition Therapeutics Inc Composiciones de isoindolina y métodos para tratar una enfermedad neurodegenerativa.
BR112019023851A2 (pt) * 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
KR102224918B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
PT813416E (pt) * 1995-03-06 2005-10-31 Interneuron Pharma Reducao do volume de enfarte usando citicolina
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
TW585766B (en) 2004-05-01
SA98190747B1 (ar) 2006-11-04
MY120461A (en) 2005-10-31
BG64819B1 (bg) 2006-05-31
OA11464A (en) 2003-11-18
EE200000290A (et) 2001-06-15
SK286040B6 (sk) 2008-01-07
IL136122A0 (en) 2001-05-20
BR9814035A (pt) 2000-09-26
EA200000412A1 (ru) 2000-12-25
CN1243540C (zh) 2006-03-01
BG104428A (en) 2001-08-31
KR100599350B1 (ko) 2006-07-12
ID24933A (id) 2000-08-31
IL136122A (en) 2006-07-05
NO20002450L (no) 2000-07-14
AU1160999A (en) 1999-06-07
SK7112000A3 (en) 2000-10-09
KR20010032099A (ko) 2001-04-16
CO4980891A1 (es) 2000-11-27
NZ504420A (en) 2003-08-29
PL194597B1 (pl) 2007-06-29
WO1999025363A1 (fr) 1999-05-27
AU743228B2 (en) 2002-01-24
NO20002450D0 (no) 2000-05-11
EP1030671A1 (fr) 2000-08-30
CN1285742A (zh) 2001-02-28
EE04235B1 (et) 2004-02-16
CA2309966A1 (en) 1999-05-27
UY25247A1 (es) 2001-05-31
EA003255B1 (ru) 2003-02-27
HUP0100098A2 (hu) 2001-07-30
PL340500A1 (en) 2001-02-12
HUP0100098A3 (en) 2001-12-28
IS5482A (is) 2000-05-09
DZ2649A1 (fr) 2004-12-28
JP2001523642A (ja) 2001-11-27

Similar Documents

Publication Publication Date Title
AU4437896A (en) Piperidine derivatives having tachykinin antagonist activity
HUT60733A (en) Process for producing new n-(4-piperidinyl)-(dihydrobenzofuran or dihydro-2h-benzopyran)-carboxamide derivatives and pharmaceutical compositions comprising such compounds
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
TR199801211T2 (xx) Takikinin resept�r antagonistleri olarak 1-(1,2-�ift-ikameli piperidinil ) -4-ikameli piperidin t�revleri.
MEP12708A (en) Derivatives of n-[phenyl (alkylpiperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
TR199801210T2 (xx) 1-(1,2-�ift ikameli piperidinil)-4-(kayna�m�� imidazol)piperidin t�revleri.
TR200001262T2 (tr) Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu
NO20000722L (no) 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater
NZ320355A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
MXPA04001364A (es) Uso de bibn4096 en combinacion con otros farmacos anti-migrana para el tratamiento de migrana, composicion y equipo.
NO961797L (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
FI955387A0 (fi) 4(p-fluorifenyyli)-3-((3,4-(metyleenioksi)fenoksi)metyyli)-piperidiinin N-p-halobentsoyylimetyylijohdannaiset
NZ336033A (en) 4-substituted 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
ATE209172T1 (de) 1,3-diphenylpropanderivate mit hemmender aktivität gegen tyrosinase und verfahren zu deren herstellung
TR199800407T1 (xx) 4-(Sikloalkil) piperidin ve t�revleri, haz�rlan��lar�, tedavi ama�l� kullan�mlar�.
AR037963A1 (es) Piperidin-2,6-diona sustituida con heterociclo en la posicion 3, procedimiento para prepararla, medicamento que la contiene y su uso para preparar este ultimo
TW200616999A (en) Novel pyridine derivatives
ATE261439T1 (de) Herstellung von amimide abgeleitet von 6-hydroxy- 2,5,7,8-tetramethylchroman-2-säure